U.S. Markets close in 5 hrs 10 mins

Horizon Pharma Public Limited Company (HZNP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.895+0.06 (+0.46%)
As of 10:50AM EDT. Market open.
People also watch
Full screen
Previous Close11.470
Bid11.890 x 600
Ask11.890 x 100
Day's Range11.690 - 11.930
52 Week Range9.450 - 23.440
Avg. Volume4,648,329
Market Cap1.94B
PE Ratio (TTM)-9.00
EPS (TTM)-1.32
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.91
Trade prices are not sourced from all markets
  • Capital Cube19 hours ago

    Horizon Pharma Plc – Value Analysis (NASDAQ:HZNP) : June 28, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Horizon Pharma Plc a score of 22. Our analysis is based on comparing Horizon Pharma Plc with the following peers – Amgen Inc., Aralez Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Radius Health Inc, Alder Biopharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Merck & Co., Inc., BioSpecifics ... Read more (Read more...)

  • Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : June 27, 2017
    Capital Cube2 days ago

    Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : June 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Horizon Pharma Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • GlobeNewswire2 days ago

    Horizon Pharma plc Announces District Court Decision to Uphold VIMOVO® (naproxen/esomeprazole magnesium) Patents

    DUBLIN, Ireland, June 27, 2017-- Horizon Pharma plc, a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible ...